Atherosclerosis

"Atherosclerosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA.

Descriptor ID	D050197
MeSH Number(s)	C14.907.137.126.307
Concept/Terms	Atherosclerosis Atherosclerosis Atheroscleroses Atherogenesis Atherogenesis

Below are MeSH descriptors whose meaning is more general than "Atherosclerosis".

Diseases [C]
Cardiovascular Diseases [C14]
Vascular Diseases [C14.907]
Arterial Occlusive Diseases [C14.907.137]
Arteriosclerosis [C14.907.137.126]
Atherosclerosis [C14.907.137.126.307]

Below are MeSH descriptors whose meaning is related to "Atherosclerosis".

Below are MeSH descriptors whose meaning is more specific than "Atherosclerosis".

Atherosclerosis
Peripheral Arterial Disease

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Atherosclerosis" by people in this website by year, and whether "Atherosclerosis" was a major or minor topic of these publications.

Bar chart showing 518 publications over 18 distinct years, with a maximum of 49 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	18	3	21
2006	17	5	22
2007	20	6	26
2008	16	4	20
2009	13	10	23
2010	11	7	18
2011	29	9	38
2012	18	6	24
2013	25	4	29
2014	31	9	40
2015	28	2	30
2016	20	7	27
2017	34	14	48
2018	19	2	21
2019	41	8	49
2020	27	5	32
2021	30	3	33
2022	17	0	17

Below are the most recent publications written about "Atherosclerosis" by people in Profiles.

Obisesan OH, Kou M, Wang FM, Boakye E, Honda Y, Uddin SMI, Dzaye O, Osei AD, Orimoloye OA, Howard-Claudio CM, Coresh J, Blumenthal RS, Hoogeveen RC, Budoff MJ, Matsushita K, Ballantyne CM, Blaha MJ. Lipoprotein(a) and Subclinical Vascular and Valvular Calcification on Cardiac Computed Tomography: The Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2022 Jun 07; 11(11):e024870.

View in: PubMed
Peng X, Lian Z, Perrard XD, Xiao Y, Ni J, O'Brien V, Dong H, Pownall HJ, Ballantyne CM, Wu H. Poloxamer 407 Induces Hypertriglyceridemia but Decreases Atherosclerosis in Ldlr-/- Mice. Cells. 2022 May 30; 11(11).

View in: PubMed
Jia X, Sun C, Nambi V, Virani SS, Taffet G, Boerwinkle E, Bressler J, Ndumele C, Windham BG, de Lemos JA, Matsushita K, McEvoy JW, Hoogeveen RC, Selvin E, Ballantyne CM. Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 2022 06; 350:82-89.

View in: PubMed
Ballantyne CM, Banach M, Bays HE, Catapano AL, Laufs U, Stroes ESG, Robinson P, Lei L, Ray KK. Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study). Am J Cardiol. 2022 Jul 01; 174:1-11.

View in: PubMed
Gao F, Rahman F. DOACs and Atherosclerotic Cardiovascular Disease Management: Can We Find the Right Balance Between Efficacy and Harm. Curr Atheroscler Rep. 2022 Jun; 24(6):457-469.

View in: PubMed
Jain V, Rifai MA, Brinzevich D, Taj M, Saleh M, Krittanawong C, Patel J, Patel A, Lee MT, Mahtta D, Virani SS. Association of premature atherosclerotic cardiovascular disease with higher risk of cancer: a behavioral risk factor surveillance system study. Eur J Prev Cardiol. 2022 Mar 25; 29(3):493-501.

View in: PubMed
Abe RJ, Abe JI, Nguyen MTH, Olmsted-Davis EA, Mamun A, Banerjee P, Cooke JP, Fang L, Pownall H, Le NT. Free Cholesterol Bioavailability and Atherosclerosis. Curr Atheroscler Rep. 2022 05; 24(5):323-336.

View in: PubMed
Erqou S, Papaila A, Halladay C, Ge A, Liu MA, Jiang L, Lally M, Menon A, Shah NR, Miech E, Virani SS, Zullo AR, Shireman TI, Longenecker CT, Ross D, Sullivan JL, Wu WC, Rudolph JL. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease. Am Heart J. 2022 07; 249:12-22.

View in: PubMed
Al Rifai M, Vaughan EM, Abushamat LA, Lee M, Ramsey DJ, Gupta K, Navaneethan SD, Virani SS. Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs). Am J Cardiol. 2022 Jun 01; 172:7-10.

View in: PubMed
Hussain A, Sun C, Selvin E, Nambi V, Coresh J, Jia X, Ballantyne CM, Hoogeveen RC. Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study. Eur J Prev Cardiol. 2022 03 11; 29(2):e53-e64.

View in: PubMed

People

Explore

Similar Concepts

Top Journals